Clinical trial Recruiting at 1 site Observational Ages 18 and up

Examining the link between CT scans, bone density, and hearing loss in otosclerosis patients

Official title: Radiological and Audiological Correlation in Otosclerosis: a Prospective Case-Control Study Evaluating Temporal Bone CT, Bone Mineral Density, and Hearing Loss

Run by Hacettepe University · NCT06830187 · Data updated 2026-11-12

This study is trying to see if there's a connection between CT scan results, bone density, and hearing loss in adults with otosclerosis compared to those without the condition.

More Vitamin D Deficiency trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment86 (estimated)
SponsorHacettepe University
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedMarch 1, 2025
Study endsMay 1, 2025
Registry record updatedFebruary 20, 2025
Trial IDNCT06830187 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults diagnosed with otosclerosis who have undergone relevant imaging and audiological assessments.

Probably not a fit

Patients with primary metabolic bone diseases or those on medications affecting bone metabolism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the relationship between temporal bone CT findings, bone mineral density (BMD), and hearing loss in adults diagnosed with otosclerosis. Researchers will compare patients with otosclerosis to a control group without the condition to assess correlations between CT density values and hearing loss severity. Participants will undergo BMD assessments, serum vitamin D level measurements, and audiological testing, utilizing existing CT scans from routine evaluations. The study seeks to uncover potential systemic bone metabolism markers associated with otosclerosis.

Why it matters

Potential benefit: If successful, this study could enhance understanding of the relationship between bone health and hearing loss in otosclerosis, potentially leading to improved treatment strategies.

How similar studies have gone: While the specific approach of this study is relatively novel, similar studies have explored the relationship between bone density and hearing loss, indicating potential for meaningful insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (Otosclerosis Group):

* Adults diagnosed with otosclerosis based on audiological and clinical assessment
* Patients with available high-resolution CT scans and audiological data
* Individuals who have undergone stapedectomy or stapedotomy surgery
* Availability of bone mineral density and serum vitamin D data

Inclusion Criteria (Control Group):

* Patients without otosclerosis but with temporal CT imaging for other indications
* No history of conductive or mixed hearing loss
* Availability of BMD and vitamin D data

Exclusion Criteria:

* History of primary metabolic bone diseases (osteoporosis, Paget's disease)
* Use of medications affecting bone metabolism (bisphosphonates, corticosteroids)
* History of chronic otitis media or prior ear surgeries
* Patients who received head and neck radiotherapy

Where it's running

  • Hacettepe University Hospitals
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.